According to our results, other studies in LUAD revealed that KYNU expression is associated with an immunosuppressive TME, with an increase in the number of Tregs in the tumor mass and an increase in the amount of PD-1 and PD-L1 protein [38]. The gene discussed is CD274; the disease is neoplasm.